The scientists found that administering the adjuvant with the vaccine yielded a two-fold increase in gut mucosal antibodies.

Cellares will automate the TSC-101 manufacturing and testing processes on the Cell Shuttle and the Cell Q automated testing ...

Researchers discover manikomycin, a novel antibiotic that kills drug-resistant bacteria by targeting a previously unknown ribosomal target.

Researchers have uncovered a previously underappreciated mechanism that helps immune cells respond rapidly to infections.

Novel stem cell separation technologies target scalable bioprocessing with improved yield, viability, and therapeutic consistency.

In this GEN webinar, Erdinc Sezgin, PhD, Karolinska Institutet, will present how his lab profiled plasma membrane order ...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...

Dr. George is a physician-scientist whose clinical expertise is in disorders of hemostasis and thrombosis with a particular interest in hemophilia and hemophilia gene therapy. Her basic science ...

Early results reveal how a single‑cell spatial platform maps stromal barriers that limit antibody delivery and target engagement in human solid tumors.

The global biopharma industry is placing increasing importance on regional support rather than only centralized expertise to help complex programs advance. A key benefit is access to local expertise ...

Fulcrum Therapeutics said today it is scrapping its lead pipeline program to develop pociredir as a treatment for sickle cell disease (SCD) and launching a “comprehensive” review of strategic ...

Cellular phase separation may play a previously underappreciated role in regulating kinase activity, offering therapeutic ...